What is Invaio Sciences?
Headquartered in Cambridge, Massachusetts, and founded by Flagship Pioneering in 2018, Invaio Sciences operates as a multi-platform technology firm dedicated to unlocking the potential of interdependent biological systems. The company specializes in refining agricultural practices by developing novel, integrated solutions that target pests while protecting beneficial insects and reducing reliance on traditional chemical pesticides. By integrating expertise from diverse fields such as plant physiology and advanced manufacturing, Invaio is effectively positioning itself as a leader in the next generation of sustainable agriculture. Their unique methodology aims to solve pressing global challenges, ensuring that food production remains both efficient and environmentally responsible.
How much funding has Invaio Sciences raised?
Invaio Sciences has raised a total of $138.9M across 2 funding rounds:
Series C
$88.9M
Debt
$50M
Series C (2021): $88.9M with participation from Stage 1 Ventures, Alexandria Venture Investments, and Bluwave Capital
Debt (2021): $50M led by K2 HealthVentures
Key Investors in Invaio Sciences
Stage 1 Ventures
A venture capital firm focused on investing in early-stage companies that are transforming global industries through disruptive deep tech and science.
K2 HealthVentures
An alternative investment firm providing flexible, long-term financing solutions to innovative private and public companies in the life sciences and healthcare industries.
Alexandria Venture Investments
A strategic venture capital arm that invests in innovative life science and technology companies to drive advancements in human health and agriculture.
What's next for Invaio Sciences?
With the infusion of $50M, Invaio Sciences is poised to scale its operational capabilities and expand its research and development pipeline. The company's strategic roadmap focuses on commercializing its proprietary technology platforms, which are designed to enhance crop health and yield while minimizing ecological footprints. As the firm transitions into a more mature phase of its lifecycle, the focus will likely shift toward broader market adoption and the establishment of strategic partnerships within the global agricultural supply chain. Investors remain optimistic that Invaio's commitment to science-based, sustainable solutions will provide a significant competitive advantage in an increasingly resource-constrained world.
See full Invaio Sciences company page
